The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19

BACKGROUND: Molnupiravir (MOL) is an oral antiviral medication that has recently been treated for COVID-19. OBJECTIVELY: We perform a prospective and observational study to elucidate the efficacy and safety of MOL in healthcare patients with COVID-19. MATERIALS AND METHODS: A observational, non-rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shih-Lung, Wang, Ping-Huai, Chang, Cheng-Yu, Wang, Hsu-Hui, Wang, Chung-Jen, Chiu, Kuan-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869894/
https://www.ncbi.nlm.nih.gov/pubmed/36698540
http://dx.doi.org/10.2147/DDDT.S392708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869894/
https://www.ncbi.nlm.nih.gov/pubmed/36698540
http://dx.doi.org/10.2147/DDDT.S392708

Ejemplares similares